Literature DB >> 7489792

Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis.

J Behr1, B Degenkolb, K Maier, B Braun, T Beinert, F Krombach, C Vogelmeier, G Fruhmann.   

Abstract

An unbalanced oxidative stress is thought to be an important element in the pathogenesis of diffuse fibrosing alveolitis (DFA). The purpose of our study was to investigate the role of reactive oxygen metabolites (ROMs) released from cultured bronchoalveolar inflammatory cells (BA-cells) on glutathione oxidation. We studied bronchoalveolar lavage samples from 10 healthy controls and from 20 patients with diffuse fibrosing alveolitis (all were nonsmokers). BA-cells obtained by bronchoalveolar lavage (BAL) were incubated with 50 microM of reduced glutathione (GSH). Oxidation of GSH to glutathione disulphide (GSSG) by BA-cell derived oxidants was detected as a decline of GSH in the supernatants. Total glutathione (GSHtot = GSH + 2 GSSG) and GSSG in the epithelial lining fluid (ELF), and methionine sulphoxide (Met(O)) content of BAL proteins were determined. In diffuse fibrosing alveolitis the oxidative activity of BA-cells was enhanced, GSHtot and GSH were decreased, whereas the GSSG:GSH ratio was increased. The oxidative activity of BA-cells correlated positively with the GSSG:GSH ratio, but not with the methionine sulphoxide content. The methionine sulphoxide content was elevated in diffuse fibrosing alveolitis and inversely correlated with GSHtot. The methionine sulphoxide content also correlated positively with the percentage of BAL neutrophils. We conclude that BA-cell-derived reactive oxygen species are capable of oxidizing extracellular GSH in vitro. The positive correlation between the BA-cell oxidative activity in vitro and GSSG:GSH ratio in ELF suggests that a similar oxidative effect on extracellular GSH may also occur in vivo.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489792     DOI: 10.1183/09031936.95.08081286

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  14 in total

Review 1.  [Good sense and nonsense of antitussive agents].

Authors:  A Gillissen; S Tasci; S Ewig; H Schäfer; S Zielen
Journal:  Internist (Berl)       Date:  2001-01       Impact factor: 0.743

Review 2.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

3.  S-CMC-Lys-dependent stimulation of electrogenic glutathione secretion by human respiratory epithelium.

Authors:  F Guizzardi; S Rodighiero; A Binelli; S Saino; E Bononi; S Dossena; M L Garavaglia; C Bazzini; G Bottà; M Conese; L Daffonchio; R Novellini; M Paulmichl; G Meyer
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

4.  In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis.

Authors:  Simona Inghilleri; Patrizia Morbini; Tiberio Oggionni; Sergio Barni; Carla Fenoglio
Journal:  Histochem Cell Biol       Date:  2005-11-24       Impact factor: 4.304

Review 5.  Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy.

Authors:  Vuokko L Kinnula; Cheryl L Fattman; Roderick J Tan; Tim D Oury
Journal:  Am J Respir Crit Care Med       Date:  2005-05-13       Impact factor: 21.405

6.  CFTR directly mediates nucleotide-regulated glutathione flux.

Authors:  Ilana Kogan; Mohabir Ramjeesingh; Canhui Li; Jackie F Kidd; Yanchun Wang; Elaine M Leslie; Susan P C Cole; Christine E Bear
Journal:  EMBO J       Date:  2003-05-01       Impact factor: 11.598

7.  Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress.

Authors:  Anne M Fitzpatrick; W Gerald Teague; Fernando Holguin; Mary Yeh; Lou Ann S Brown
Journal:  J Allergy Clin Immunol       Date:  2009-01       Impact factor: 10.793

8.  Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis.

Authors:  Moises Selman; Hung-Mo Lin; Martha Montaño; Audrey L Jenkins; Andrea Estrada; Zhenwu Lin; Guirong Wang; Susan L DiAngelo; Xiaoxuan Guo; Todd M Umstead; C Max Lang; Annie Pardo; David S Phelps; Joanna Floros
Journal:  Hum Genet       Date:  2003-09-06       Impact factor: 4.132

9.  Chemoprevention by N-acetylcysteine of low-dose CT-induced murine lung tumorigenesis.

Authors:  Mark Steven Miller; Joseph E Moore; Matthew C Walb; Nancy D Kock; Albert Attia; Scott Isom; Jennifer E McBride; Michael T Munley
Journal:  Carcinogenesis       Date:  2012-10-26       Impact factor: 4.944

10.  Clinical importance of Bcl-2-like 11 deletion polymorphism in idiopathic pulmonary fibrosis.

Authors:  Kazutoshi Isobe; Takuma Issiki; Susumu Sakamoto; Go Sano; Yujiro Takai; Naobumi Tochigi; Sakae Homma
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.